Wallace Advisory Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,702
Closed -$203K 184
2022
Q4
$203K Buy
+1,702
New +$203K 0.16% 146